Lotus Pharmaceuticals, Inc. (LTUS)
OTCMKTS · Delayed Price · Currency is USD
0.00395
0.00 (0.00%)
At close: Jul 29, 2026
Lotus Pharmaceuticals Market Cap
Lotus Pharmaceuticals has a market cap or net worth of $10.45 million as of July 31, 2026. Its market cap has decreased by -53.53% in one year.
Market Cap
10.45M
Enterprise Value
n/a
Revenue
71.39M
Ranking
n/a
PE Ratio
0.06
Stock Price
$0.00
ChartMarket Cap Chart
Since October 4, 2006, Lotus Pharmaceuticals's market cap has decreased from 165.12M to 10.45M, a decrease of -93.67%. That is a compound annual growth rate of -13.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 10.45M | 31.67% |
| Dec 31, 2025 | 7.93M | -50.00% |
| Dec 31, 2024 | 15.87M | 26.79% |
| Dec 29, 2023 | 12.51M | -57.50% |
| Dec 30, 2022 | 29.45M | -41.00% |
| Dec 31, 2021 | 49.91M | 54.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Everest Consolidator Acquisition | 14.32M |
| Longevity Diversified Holdings | 14.22M |
| Public Company Management | 13.71M |
| Pegasus Tel | 11.88M |
| Non-Invasive Monitoring Systems | 10.91M |
| Elah Holdings | 10.90M |
| Maquia Capital Acquisition | 10.75M |
| Xenous Holdings | 10.64M |